Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer Read more about Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer Germany18188913.0Filed on 2018-08-14
Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer Read more about Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer Switzerland18188913.0Filed on 2018-08-14
Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer Read more about Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer Belgium18188913.0Filed on 2018-08-14
Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer Read more about Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer Austria18188913.0Filed on 2018-08-14
PLASMA AUTOANTIBODY BIOMARKERS FOR BASAL LIKE BREAST CANCER Read more about PLASMA AUTOANTIBODY BIOMARKERS FOR BASAL LIKE BREAST CANCER US Patent 11,525,831Filed on 2020-01-15
Plasma Autoantibody Biomarkers For Diagnosis Of Basal-like Breast Cancer Read more about Plasma Autoantibody Biomarkers For Diagnosis Of Basal-like Breast Cancer US Application 15/534,203Filed on 2017-06-08
IMMUNORESPONSIVE CELLS EXPRESSING DOMINANT NEGATIVE FAS AND USES THEREOF Read more about IMMUNORESPONSIVE CELLS EXPRESSING DOMINANT NEGATIVE FAS AND USES THEREOF Australia2019347873Filed on 2019-09-30
Anti-Human Papillomavirus 16 E7 T Cell Receptors Read more about Anti-Human Papillomavirus 16 E7 T Cell Receptors Israel282518Filed on 2021-04-21
Photosensitizing Antibody-Flurophore Conjugates Read more about Photosensitizing Antibody-Flurophore Conjugates Japan2021-67756Filed on 2021-04-13
METHODS FOR ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR CANCER SPECIFIC MUTATIONS Read more about METHODS FOR ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR CANCER SPECIFIC MUTATIONS Japan2021-076293Filed on 2021-04-28